Scott Burrows

Scott Burrows

Chief Financial OfficeratSpyre Therapeutics· In proxies 2023–2025

Pay in FY2025-1% from the year before · Spyre Therapeutics stock +40.7% the same year

Scott Burrows was paid $2.2M in FY2025 (Dec), down 1%. Spyre Therapeutics stock rose 40.7% that year.

Pay$100 in the stock at the end of FY22 → $291
Pay is from the Summary Compensation Table of each Spyre Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Spyre TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +928%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?